Emad Shash: 6 Abstracts Have Been Officially Accepted to the Prestigious ESMO 2025 Congress
Emad Shash, General Manager at National Cancer Institute, Cairo University, shared a post on LinkedIn:
“Our team is thrilled to share that 6 abstracts submitted to the prestigious ESMO 2025 Congress have been officially accepted!
This recognition reflects the vibrant, multidisciplinary, and collaborative research ecosystem we are building – spanning from the National Cancer Institute (NCI) Breast Cancer Comprehensive Center to multi-institutional efforts, in partnership with NGOs, the private sector, and the Presidential Initiative for Women’s Health.
Topics covered include:
- Access to timely diagnosis and treatment
- Adherence to therapy and patient-centered interventions
- Time-efficiency of care delivery
- Marital and psychological dynamics in young women
- Lessons from large-scale partnerships in LMICs
This achievement comes in addition to other outstanding work by fellow colleagues from various Egyptian institutions, whose research has also been accepted at ESMO 2025 – showcasing the growing footprint of Egyptian oncology on the global stage.
We look forward to joining the international oncology community in Berlin this October (17–21, 2025) to share insights, learn, and collaborate at ESMO 2025, one of the world’s most prestigious cancer platforms.
Together, we advance science, equity, and impact.”
More posts featuring Emad Shash.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023